Medmain Speaks

~Official Blog~

Certified as a Special Startup of the J-Startup Program!

We were certified as one of the special startup of the J-Startup program promoted by the Ministry of Economy, Trade and Industry of Japan!

Posted by Daiki Wednesday, June 26, 2019

Won First Place at “Make Money UNDER30”!

Our CEO, Osamu Iizuka appeared on the Entrepreneurial Reality Show “Make Money UNDER30” hosted by NewsPicks and won first place! Mr. Takafumi Horie and the NewsPicks All Stars loved the idea about our software for pathological image diagnosis with AI, “PidPort”. We would like to thank everyone for their great support. Thank you very much!

Posted by Daiki Sunday, April 7, 2019

Won the MIC Awards at NICT Entrepreneurs’ Challenge 2Days!

On March 12th, we participated in the NICT Entrepreneurs’ Challenge 2Days held by The Ministry of Internal Affairs and Communications (MIC) and National Institute of Information and Communications Technology (NICT) and won the best award, the “MIC Awards”! We were also awarded with “NTT Data Awards”, “Fujitsu Awards”, “TIS Incubation Center Awards” and “IBM Blue Hub Awards”.

Posted by Daiki Saturday, April 6, 2019

“Digital Pathology & AI Congress” in London.

On 6th and 7th of December, We participated in “Digital Pathology & AI Congress” in London where the Christmas atmosphere prevailed everywhere.

Posted by Daiki Tuesday, December 11, 2018

Medmain Inc. has raised ¥100million from DEEPCORE and DOGANβ

Medmain Inc. (Fukuoka City, CEO:Osamu Iizuka) has raised ¥100million from DEEPCORE, the AI specialized VC, and DOGANβ, the Kyushu-district specialized VC. Medmain is currently developing “PidPort”, the software for pathological image diagnosis using DeepLearning,

Posted by Daiki Saturday, August 18, 2018

FEATURED TAGS
news pathology people & culture pidport
ABOUT US
about us

Medmain is a health tech start up which is developing and providing "PidPort," a marketplace for pathological image diagnosis, which includes Deep Learning driven immediate pathological analysis. In this company blog "Medmain Speaks", we would like to write and post articles about our news, people/culture and pathology-focused columns.